This compound is a pharmaceutical intermediate featuring an amide-linked glycine residue and a benzyl side chain. It is characterized by a sulfonate ester group and an aromatic ring, with a molecular weight of approximately 315 Da and moderate polarity.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 1852472-89-9
(R)-Ethyl 2-(2-benzyl-3-((methylsulfonyl)oxy)propanamido)acetate
pharmaceutical impurity reference standard
(S)-Ethyl 2-(2-benzyl-3-((methylsulfonyl)oxy)propanamido)acetate
pharmaceutical intermediate
Methyl 2-((2R,4aS,6S,7R,8S,8aS)-7,8-bis((tert-butyldimethylsilyl)oxy)-6-((S,E)-1-((tert-butyldimethylsilyl)oxy)-3-(trimethylsilyl)allyl)octahydropyrano[3,2-b]pyran-2-yl)acetate
pharmaceutical intermediate for eribulin
Magnesium bromide 4-methoxy-3,5-dimethylbenzen-1-ide (1/1/1)
Grignard reagent for organic synthesis
Agomelatine Dimer Urea
pharmaceutical impurity reference standard
O-Desmethyl Tramadol Hydrochloride
Impurity standard for tramadol hydrochloride
2-[[(2S)-2-benzyl-3-methylsulfonyloxypropanoyl]amino]acetic acid
FREXHGIWGSQYED-NSHDSACASA-N
CS(=O)(=O)OC[C@H](CC1=CC=CC=C1)C(=O)NCC(=O)O
—